Isolation of Bacteriocin-producing Staphylococcus spp. Strains from Human Skin Wounds, Soft Tissue Infections and Bovine Mastitis - Publication - Bridge of Knowledge

Search

Isolation of Bacteriocin-producing Staphylococcus spp. Strains from Human Skin Wounds, Soft Tissue Infections and Bovine Mastitis

Abstract

A collection of 206 Staphylococcus spp. isolates was investigated for their ability to produce compounds exhibiting antistaphylococcal activity. This group included Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus xylosus strains recovered from bovine mastitis (n = 158) and human skin wounds and soft tissues infections (n = 48). Production of substances with antimicrobial activity was observed in six strains. Five of them were recovered from bovine mastitis, and one was isolated from the infected human skin wound. Three of the six antimicrobials produced by the different strains showed substantial loss of antimicrobial activity upon treatment with proteolytic enzymes, which suggests their peptidic structure. Additional studies have shown that one of the putative bacteriocins was efficiently secreted to the liquid medium, facilitating its large-scale production and isolation. The peptide produced by the M2B strain exhibited promising activity; however, against narrow spectrum of Staphylococcus spp. clinical and animal isolates. Growth inhibition was observed only in the case of 13 (including nine S. aureus, three S. xylosus and one S. epidermidis strains) out of 206 strains tested. Important advantage of the produced agent was its high thermal stability. Fifteen minutes of incubation at 90°C did not affect its antimicrobial potential. The highest efficiency of production of the agent was demonstrated in TSB medium after 24 hours at 37°C. The researches revealed that ability to production of bacteriocin among staphylococci is not very common. Only one (S. xylosus strain assigned as M2B) out of 206 strains tested produced satisfactory amounts of antistaphylococcal bacteriocin. In spite of that, we would encourage other researchers for investigation of their collections of Staphylococcus spp. isolates towards selection strains producing antimicrobial agents.

Citations

  • 3

    CrossRef

  • 0

    Web of Science

  • 3

    Scopus

Cite as

Full text

download paper
downloaded 20 times
Publication version
Accepted or Published Version
License
Creative Commons: CC-BY-NC-ND open in new tab

Keywords

Details

Category:
Articles
Type:
artykuł w czasopiśmie wyróżnionym w JCR
Published in:
Polish Journal of Microbiology no. 67, edition 2, pages 163 - 169,
ISSN: 1733-1331
Language:
English
Publication year:
2018
Bibliographic description:
Magdalena Z., Churey J., Worobo R., Milewski S., Szweda P.: Isolation of Bacteriocin-producing Staphylococcus spp. Strains from Human Skin Wounds, Soft Tissue Infections and Bovine Mastitis// Polish Journal of Microbiology. -Vol. 67, iss. 2 (2018), s.163-169
DOI:
Digital Object Identifier (open in new tab) 10.21307/pjm-2018-018
Bibliography: test
  1. Andersson D.I., D. Hughes and J.Z. Kubicek-Sutherland. 2016. Mechanisms and consequences of bacterial resistance to anti- microbial peptides. Drug Resist. Updat. 26: 43-57. open in new tab
  2. Barefoot S.F. and T.R. Klaenhammer. 1983. Detection and activity of lactacin B, a bacteriocin produced by Lactobacillus acidophilus. Appl. Environ. Microbiol. 45: 1808-1815. open in new tab
  3. Bastos M.C.F., H. Ceotto, M.L.V. Coelho and J.S. Nascimento. open in new tab
  4. Staphylococcal antimicrobial peptides: relevant properties and potential biotechnological applications. Curr. Pharm. Biotechnol. 10: 38-61. open in new tab
  5. Braem G., B. Stijlemans, W. Van Haken, S. De Vliegher, L. De Vuyst and F. Leroy. 2014. Antibacterial activities of coagulase- negative staphylococci from bovine teat apex skin and their inhibi- tory effect on mastitis-related pathogens. J. Appl. Microbiol. 116: 1084-1093. open in new tab
  6. Brito M.A.V.P., G.A. Somkuti and J.A. Renye. 2011. Production of antilisterial bacteriocins by staphylococci isolated from bovine milk1. J. Dairy Sci. 94: 1194-1200. open in new tab
  7. Di Meo F., G. Fabre, K. Berka, T. Ossman, B. Chantemargue, M. Paloncýová, P. Marquet, M. Otyepka and P. Trouillas. 2016. In silico pharmacology: Drug membrane partitioning and crossing. Pharmacol. Res. 111: 471-486.
  8. Fleming H.P., J.L. Etchells and R.N. Costilow. 1975. Microbial inhibition by an isolate of Pediococcus from Cucumber Brines 1. Appl. Microbiol. 30: 1040-1042. open in new tab
  9. Hewelt-Belka W., J. Nakonieczna, M. Belka, T. Bączek, J. Namieś- nik and A. Kot-Wasik. 2016. Untargeted lipidomics reveals differ- ences in the lipid pattern among clinical isolates of Staphylococ- cus aureus resistant and sensitive to antibiotics. J. Proteome Res. 4: 914-22. open in new tab
  10. Jakubczak A., P. Szweda, K. Łukaszewska and J. Kur. 2007. Molec- ular typing of Staphylococcus aureus isolated from cows with mastitis in the east of Poland on the basis of polymorphism of genes coding protein A and coagulase. Pol. J. Vet. Sci. 10: 199-205.
  11. Joerger R.D. 2003. Alternatives to antibiotics: bacteriocins, anti- microbial peptides and bacteriophages. Poultry Sci. 82: 640-647. open in new tab
  12. Kosikowska P. and A. Lesner. 2016. Antimicrobial peptides (AMPs) as drug candidates: a patent review (2003-2015). Expert Opin. Ther. Pat. 26: 689-702. open in new tab
  13. Kot B., M. Piechota, M. Antos-Bielska, E. Zdunek, K.M. Wolska, T. Binek, J. Olszewska, P. Guliński and E.A. Trafny. 2012. Anti- microbial resistance and genotypes of staphylococci from bovine milk and the cowshed environment. Pol. J. Vet. Sci. 15: 741-749. open in new tab
  14. Kurlenda J. and M. Grinholc. 2012. Alternative therapies in Staphy- lococcus aureus diseases. Acta Biochim. Pol. 59: 171-184. open in new tab
  15. Lee H., J. Churey and R. Worobo. 2008. Antimicrobial activity of bacterial isolates from different floral sources of honey. Int. J. Food Microbiol. 126: 240-244. open in new tab
  16. Malanovic N. and K. Lohner. 2016. Antimicrobial peptides target- ing Gram-positive bacteria. Pharmaceuticals (Basel). 9(3). pii: E59. doi: 10.3390/ph9030059. open in new tab
  17. Nascimento J.S., H. Ceotto, S.B. Nascimento, M. Giambiagi- Demarval, K.N. Santos and M.C.F. Bastos. 2006. Bacteriocins as alternative agents for control of multiresistant staphylococcal strains. Lett. Appl. Microbiol. 42: 215-221. open in new tab
  18. Nes I.F. 2011. History, Current Knowledge, and Future Directions on Bacteriocin Research in Lactic Acid Bacteria. In: Drider D. and S. Rebuffat (eds). Prokaryotic Antimicrobial Peptides. Springer, New York, NY open in new tab
  19. Ołdak A. and D. Zielińska. 2017. Bacteriocins from lactic acid bac- teria as an alternative to antibiotics. Post. Hig. Med. Dosw. 71: 328-338. open in new tab
  20. Powers J.-P.S. and R.E. Hancock. 2003. The relationship between peptide structure and antibacterial activity. Peptides 24: 1681-1691. open in new tab
  21. Rashid R., M. Veleba and K.A. Kline. 2016. Focal targeting of the bacterial envelope by antimicrobial peptides. Front. Cell Dev. Biol. 4:55. doi: 10.3389/fcell.2016.00055. open in new tab
  22. Schillinger U. and F.K. Lücke. 1989. Antibacterial activity of Lac- tobacillus sake isolated from meat. Appl. Environ. Microbiol. 55: 1901-1906. open in new tab
  23. Sjölund M. and G. Kahlmeter. 2008. Staphylococci in primary skin and soft tissue infections in a Swedish county. Scand. J. Inf. Dis. 40: 894-898. open in new tab
  24. Szweda P., M. Schielmann, A. Frankowska, B. Kot and M. Zalew- ska. 2014. Antibiotic resistance in Staphylococcus aureus strains isolated from cows with mastitis in eastern Poland and analysis of susceptibility of resistant strains to alternative nonantibiotic agents: lysostaphin, nisin and polymyxin B. J. Vet. Med. Sci. 76: 355-362. open in new tab
  25. Varella Coelho M.L., J.D. Santos Nascimento, P.C. Fagundes, D.J. Madureira, S.S Oliveira, M.A. Vasconcelos de Paiva Brito and C. Freire Bastos Mdo. 2007. Activity of staphylococcal bacteriocins against Staphylococcus aureus and Streptococcus agalactiae involved in bovine mastitis. Res. Microbiol. 158: 625-630. open in new tab
  26. Weisburg W.G., S.M. Barns, D.A. Pelletier and D.J. Lane. 1991. 16S ribosomal DNA ampigication for phylogenetic study. J. Bacte- riol. 173: 697-703. open in new tab
  27. Yeaman, M.R. and N.Y. Yount. 2003. Mechanisms of antimicrobial peptide action and resistance. Pharmacol. Rev. 55: 27-55. open in new tab
  28. This article is published in Open Access model and licensed under a Creative Commons CC BY-NC-ND 4.0, licence available at: https://creativecommons.org/licenses/by-nc-nd/4.0/ open in new tab
Sources of funding:
  • 2012/07/N/NZ9/00939
Verified by:
Gdańsk University of Technology

seen 122 times

Recommended for you

Meta Tags